γδ T Cell-Based Adoptive Cell Therapies Against Solid Epithelial Tumors

Area of Science:

• Immunology
• Oncology
• Cell Therapy

Background:

• Adoptive cell therapies traditionally utilize alpha-beta (αβ) T cells.
• Gamma delta (γδ) T cells, though less abundant, present unique immunotherapy advantages, especially for solid tumors.

Purpose of the Study:

• To review current research on γδ T cells in adoptive immunotherapy.
• To compile information on enhancing γδ T-cell expansion, phenotype, and inhibitory receptors.
• To highlight advances in preclinical and clinical research targeting solid epithelial tumors.

Main Methods:

• Literature review of preclinical and clinical studies.
• Analysis of research on γδ T-cell enhancement strategies.
• Focus on applications against solid epithelial tumors.

Main Results:

• Preclinical studies demonstrate γδ T-cell potential against various malignant cells.
• Clinical γδ T-cell immunotherapies are safe but require efficacy improvements.
• Growing interest in γδ T cells for immunotherapy is evident.

Conclusions:

• γδ T cells offer a promising avenue for solid tumor immunotherapy.
• Further research is needed to optimize γδ T-cell expansion and function.
• Enhancing γδ T-cell therapies is crucial for improving clinical outcomes.